GHRH is a 44-amino acid brain-gut peptide that binds to the growth hormone-releasing hormone receptor (GHRH-R) and stimulates the pituitary gland to produce and release more HGH [4]
and Li, J
For a small but meaningful share of people, the experience falls short, not because the medication fails outright, but because the surrounding system does
Further, the FDA-approved synthetic peptide bremelanotide, which is a naturally-occurring metabolite of MT-II, has been evaluated in clinical trials in a nasal spray format [31]
In patients who took semaglutide, there was a 17% greater rate of achieving both endpoints compared to the placebo group
We encourage patients to contact the team at Bariatric Specialists of the Carolinas to explore their weight loss options, understand the role of GLP-1 medications, and learn how these therapies compare to other surgical or non-surgical interventions